Cargando…
Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases
Recently, adeno-associated virus (AAV)-mediated gene therapies have attracted clinical interest for treating neurodegenerative diseases including spinal muscular atrophy (SMA), Canavan disease (CD), Parkinson’s disease (PD), and Friedreich’s ataxia (FA). The influx of clinical findings led to the fi...
Autores principales: | Perez, Barbara A., Shutterly, Alison, Chan, Ying Kai, Byrne, Barry J., Corti, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071492/ https://www.ncbi.nlm.nih.gov/pubmed/32098339 http://dx.doi.org/10.3390/brainsci10020119 |
Ejemplares similares
-
Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses
por: Srinivasan, Karpagam, et al.
Publicado: (2016) -
Inflammasomes in neuroinflammatory and neurodegenerative diseases
por: Voet, Sofie, et al.
Publicado: (2019) -
Role of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases
por: Lima, Isabel Vieira de Assis, et al.
Publicado: (2012) -
Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases
por: Hirschberg, Sarah, et al.
Publicado: (2019) -
Advancements in AAV-mediated Gene Therapy for Pompe Disease
por: Salabarria, S.M., et al.
Publicado: (2020)